PALLD and central nervous system cancer: Analysis of all 1130 samples (HKruskal–Wallis = 275.5, p < 0.0001, Supplementary Figure S1) revealed that, compared to healthy donor brain tissue, both primary and recurrent glioma tumors expressed roughly twice as much palladin (p < 0.0001 and p < 0.0001, respectively).